Metabolic reprogramming in non-small cell lung cancer: unraveling therapeutic vulnerabilities and resistance mechanisms

Key Points

• Resistance mechanisms significantly impact treatment effectiveness in non-small cell lung cancer, affecting patient outcomes.
• The study identifies key biomarkers associated with metabolic reprogramming in non-small cell lung cancer cases, highlighting therapeutic targets.
• Observational analysis of various treatment interventions highlights the need for innovative approaches to target metabolic vulnerabilities effectively.
• The findings point to the potential for developing tailored therapies based on metabolic profiles, indicating that more research is essential.